We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+24.59%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.9B
AUM Growth
+$12.2B
Cap. Flow
+$2B
Cap. Flow %
3.34%
Top 10 Hldgs %
21.63%
Holding
3,213
New
281
Increased
1,628
Reduced
1,147
Closed
147

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$134M
2
MSFT icon
Microsoft
MSFT
+$119M
3
AAPL icon
Apple
AAPL
+$87.6M
4
ABBV icon
AbbVie
ABBV
+$61.7M
5
META icon
Meta Platforms (Facebook)
META
+$54.9M

Sector Composition

Rank Sector Weight
1 Technology 23.43%
2 Healthcare 14.28%
3 Financials 13.11%
4 Consumer Discretionary 10.94%
5 Communication Services 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LNAI
3001
Lunai Bioworks
LNAI
$11M
$59K ﹤0.01%
+175
New +$52.8K
BHR
3002
Braemar Hotels & Resorts
BHR
$146M
$56K ﹤0.01%
19,583
-38,472
-66% -$112K
CX icon
3003
Cemex
CX
$16.3B
$56K ﹤0.01%
+19,512
New +$45.8K
MLSS icon
3004
Milestone Scientific
MLSS
$41.1M
$56K ﹤0.01%
+28,769
New +$52.7K
SIEB icon
3005
Siebert Financial
SIEB
$68M
$56K ﹤0.01%
+11,059
New +$69.7K
SEAC
3006
DELISTED
Seachange International Inc
SEAC
$56K ﹤0.01%
+1,846
New +$86.4K
BRFS
3007
DELISTED
BRF SA
BRFS
$55K ﹤0.01%
+13,881
New +$53.5K
VERO
3008
DELISTED
Venus Concept
VERO
$55K ﹤0.01%
+96
New +$61.3K
PHAS
3009
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$55K ﹤0.01%
+11,932
New +$52.8K
CHGA
3010
Change Agents Corporation Common Stock
CHGA
$2.68M
$54K ﹤0.01%
189
+76
+67% +$18.6K
TRAK icon
3011
ReposiTrak
TRAK
$158M
$54K ﹤0.01%
+12,863
New +$62K
HMY icon
3012
Harmony Gold Mining
HMY
$11.3B
$51K ﹤0.01%
+12,282
New +$40.4K
NOK icon
3013
Nokia
NOK
$52.6B
$50K ﹤0.01%
+11,305
New +$42.7K
PRTH icon
3014
Priority Technology Holdings
PRTH
$443M
$50K ﹤0.01%
+19,223
New +$36.5K
UGP icon
3015
Ultrapar
UGP
$6.81B
$48K ﹤0.01%
+14,166
New +$41.7K
KODK icon
3016
Kodak
KODK
$925M
$46K ﹤0.01%
+20,618
New +$48K
AYTU icon
3017
AYTU BioPharma
AYTU
$25M
$41K ﹤0.01%
+143
New +$43.3K
TMUSR
3018
DELISTED
T-Mobile US, Inc. Subscription Rights Expiring 7/27/2020
TMUSR
$41K ﹤0.01%
+246,074
New +$69.1K
GNLN icon
3019
Greenlane Holdings
GNLN
$1.24M
0
PANL icon
3020
Pangaea Logistics
PANL
$487M
$37K ﹤0.01%
+14,690
New +$32K
LYG icon
3021
Lloyds Banking Group
LYG
$90B
$35K ﹤0.01%
23,439
+6,533
+39% +$9.8K
VTVT icon
3022
vTv Therapeutics
VTVT
$136M
$33K ﹤0.01%
+363
New +$35.8K
AEG icon
3023
Aegon
AEG
$14B
$32K ﹤0.01%
11,878
ASNA
3024
DELISTED
Ascena Retail Group, Inc.
ASNA
$31K ﹤0.01%
21,548
+8,065
+60% +$12.2K
CWBR
3025
DELISTED
CohBar, Inc. Common Stock
CWBR
$30K ﹤0.01%
+646
New +$45.1K

Similar funds

RhumbLine Advisers's Q2 2020 Portfolio in Review

As of Q2 2020, RhumbLine Advisers held 3,213 positions worth $59.9B, up 25% from $47.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

RhumbLine Advisers deployed $2B of net new capital in Q2 2020, opening 281 new positions and adding to 1,628 existing holdings. Its largest new stake was Otis Worldwide: 701,378 shares worth $39.9M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $12.9M trimmed.

  • RhumbLine Advisers's largest Q2 2020 buy was Otis Worldwide: 701,378 shares worth $39.9M.
  • RhumbLine Advisers added most to Amazon in Q2 2020, an estimated $134M increase.
  • RhumbLine Advisers's biggest Q2 2020 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $12.9M.
  • RhumbLine Advisers fully exited Allergan plc in Q2 2020, selling an estimated $92.9M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $59.9B portfolio in Q2 2020.
  • RhumbLine Advisers opened 281 new positions and closed 147 in Q2 2020.
  • RhumbLine Advisers's portfolio value rose 25% quarter-over-quarter to $59.9B.

Based on RhumbLine Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.